Soluble amyloid precursor protein-α modulates β-secretase activity and amyloid-β generation

Obregon, Demian, Hou, Huayan, Deng, Juan, Giunta, Brian, Tian, Jun, Darlington, Donna, Shahaduzzaman, Md, Zhu, Yuyuan, Mori, Takashi, Mattson, Mark P., Tan, Jun·2012·Nature Communications
DOI 10.1038/ncomms1781

Cited by (195)

Items 101–195 of 195

  1. Soluble Amyloid Precursor Protein α: Friend or Foe?
    Nicola J. Corbett, Nigel M. Hooper · 2018 · Advances in experimental medicine and biology
  2. APPsα rescues CDK5 and GSK3β dysregulation and restores normal spine density in Tau transgenic mice
    Danny Baltissen, Charlotte S. Bold, Lena Rehra, Marija Banićević, Justus Fricke, Jennifer Just, Susann Ludewig, Christian J. Buchholz, Martin Körte, Ulrike Müller · 2023 · Frontiers in Cellular Neuroscience
  3. Acute interleukin-6 modulates key enzymes involved in prefrontal cortex and hippocampal amyloid precursor protein processing
    Daniel M. Marko, Michael S. Finch, Alex J. T. Yang, Laura N. Castellani, Willem T. Peppler, David Charles Wright, Rebecca E. K. MacPherson · 2023 · Journal of Applied Physiology
  4. Unraveling the β-amyloid clearance by astrocytes: Involvement of metabotropic glutamate receptor 3, sAPPα, and class-A scavenger receptor
    Daniela Durand, Juan Turati, María Julieta Rudi, Delia Ramírez, Julieta Saba, Carla M. Caruso, Lila Carniglia, Rommy von Bernhardi M., Mercedes Lasaga · 2019 · Neurochemistry International
  5. Temporo-spatial cellular atlas of the regenerating alveolar niche in idiopathic pulmonary fibrosis
    Praveen Nilendra Weeratunga, Bethany Hunter, Martin J. Sergeant, Joshua A. Bull, Colin Clelland, Laura Denney, Chaitanya Vuppusetty, Rachel A. Burgoyne, Jeongmin Woo, Tian Hu et al. · 2025 · Nature Communications
  6. Temporal model for central sensitization: A hypothesis for mechanism and treatment using systemic manual therapy, a focused review
    Adi Halili · 2022 · MethodsX
  7. Long noncoding RNA GAS5 acts as a competitive endogenous RNA to regulate GSK-3β and PTEN expression by sponging miR-23b-3p in Alzheimer’s disease
    Li Zeng, Kaiyue Zhao, Jianghong Liu, Mimin Liu, Zhongdi Cai, Ting Sun, Zhuorong Li, Rui Liu · 2024 · Neural Regeneration Research
  8. A Lipid-Raft Theory of Alzheimer's Disease
    Ari Rappoport · 2024 · Annual Review of Biochemistry
  9. Postexercise serum from humans influences the biological tug of war of APP processing in human neuronal cells
    Daniel M. Marko, Michael S. Finch, Ahmad Mohammad, Adam J. MacNeil, Panagiota Klentrou, Rebecca E. K. MacPherson · 2022 · American Journal of Physiology-Cell Physiology
  10. Secreted amyloid precursor protein alpha activates neuronal insulin receptors and prevents diabetes-induced encephalopathy
    Brent D. Aulston, Jason Schapansky, Ya-Wen Huang, Gary L. Odero, Gordon W. Glazner · 2018 · Experimental Neurology
  11. Involvement of diacylglycerol produced by phospholipase D activation in Aβ-induced reduction of sAPPα secretion in SH-SY5Y neuroblastoma cells
    Fuminori Tanabe, Tomoko Nakajima, Masahiko Ito · 2014 · Biochemical and Biophysical Research Communications
  12. Aerial part of Houttuynia cordata reverses memory impairment by regulating amyloid beta accumulation and neuroinflammation in Alzheimer's disease model
    In Gyoung Ju, Seungmin Lee, Jin Gyu Choi, Namkwon Kim, Eugene Huh, Jong Kil Lee, Myung Sook Oh · 2023 · Phytotherapy Research
  13. Shifting the balance: soluble ADAM10 as a potential treatment for Alzheimer's disease
    Ayelet Sarah Hershkovits, Sivan Gelley, Rawad Hanna, Oded Kleifeld, Avidor Shulman, Ayelet Fishman · 2023 · Frontiers in Aging Neuroscience
  14. Gene therapy-mediated enhancement of protective protein expression for the treatment of Alzheimer’s disease
    Lauren Owens, Alexandre Benedetto, Neil Dawson, Christopher J. Gaffney, Edward T. Parkin · 2021 · Brain Research
  15. TSPO contributes to neuropathology and cognitive deficits in Alzheimer’s disease
    Kelly Ceyzériat, Aurélien M. Badina, Laurene Abjean, Léa Meyer, Farha Bouteldja, Marta Bałkota, Quentin Amossé, Oriane Prudhomme, Ryan J. Middleton, Guo-Jun Liu et al. · 2025 · Journal of Neuroinflammation
  16. Genetic Association Between APP, ADAM10 Gene Polymorphism, and Sporadic Alzheimer’s Disease in the Chinese Population
    Fan Zeng, Cheng Shen, Yu-Hui Liu, Jing Li, Jie Zhu, Ye‐Ran Wang, Yan Jia-chuan, Chang-Yue Gao, Huadong Zhou, Juan Deng et al. · 2015 · Neurotoxicity Research
  17. Specific antibody binding to the APP672–699 region shifts APP processing from α- to β-cleavage
    Song Li, Juan Deng, H-Y Hou, Jun Tian, Brian N. Giunta, Yan‐Jiang Wang, Darrell R. Sawmiller, A Smith, Paul R. Sanberg, Demian F. Obregon et al. · 2014 · Cell Death and Disease
  18. Re-Arranging the Puzzle between the Amyloid-Beta and Tau Pathology: An APP-Centric Approach
    Florence Haut, Elentina K. Argyrousi, Ottavio Arancio · 2023 · International Journal of Molecular Sciences
  19. Human Umbilical Cord Blood Serum–derived α-Secretase
    Ahsan Habib, Huayan Hou, Takashi Mori, Jun Tian, Jin Zeng, Shengnuo Fan, Brian N. Giunta, Paul R. Sanberg, Darrell R. Sawmiller, Jun Tan · 2018 · Cell Transplantation
  20. Regressive Autism Spectrum Disorder: High Levels of Total Secreted Amyloid Precursor Protein and Secreted Amyloid Precursor Protein-α in Plasma
    Xiaoli Li, Ping Zhou, Qiu Li, Bin Peng, Yupeng Cun, Ying Dai, Hua Wei, Xiao Liu, Yang Yu, Zhiyang Jiang et al. · 2022 · Frontiers in Psychiatry
  21. Systematic review and meta-analysis of randomized controlled trials on the effects of exercise interventions on amyloid beta levels in humans
    Isabela Mayer Pucci, Andreo Fernando Aguiar, Rodrigo Mayer Pucci, Juliano Casonatto, Sérgio M. Borghi · 2024 · Experimental Brain Research
  22. The Role of Thyroid Function in Alzheimer’s Disease
    Feifei Ge, Donglin Zhu, Minjie Tian, Jingping Shi · 2021 · Journal of Alzheimer s Disease
  23. Evaluation of an Allosteric BACE Inhibitor Peptide to Identify Mimetics that Can Interact with the Loop F Region of the Enzyme and Prevent APP Cleavage.
    Jesus J. Campagna, K. Vadivel, B. Jagodzinska, Michael Jun, Tina V. Bilousova, P. Spilman, V. John · 2018 · Journal of Molecular Biology
  24. RNA Isoform Diversity in Human Neurodegenerative Diseases
    Christine S. Liu, Christopher Y. Park, Tony Ngo, Janani Saikumar, Carter R. Palmer, Anis Shahnaee, William J. Romanow, Jerold J. M. Chun · 2024 · eNeuro
  25. The thiol proteinase inhibitor E-64-d ameliorates amyloid-β-induced reduction of sAPPα secretion by reversing ceramide-induced protein kinase C down-regulation in SH-SY5Y neuroblastoma cells
    Fuminori Tanabe, Tomoko Nakajima, Masahiko Ito · 2013 · Biochemical and Biophysical Research Communications
  26. Effect of amyloid toxicity or chronic cerebral hypoperfusion on brain insulin resistance in a rat model with intracerebroventricular streptozotocin
    Bo‐Ryoung Choi, Ju-Ha Seo, Dong Bin Back, Jung‐Soo Han, Dong‐Hee Choi, Kyoung Ja Kwon, Chan Young Shin, Jongmin Lee, Hahn Young Kim · 2020 · Brain Research Bulletin
  27. Tongluo Xingnao effervescent tablet reverses memory deficit and reduces plaque load in APPswe/PS1dE9 mice
    Wenjun Fu, Yuan Dai, Tao Ma, Jiangping Wei, Huan Chen, Shijun Xu · 2018 · Experimental and Therapeutic Medicine
  28. NRF2 activation by 6-MSITC increases the generation of neuroprotective, soluble α amyloid precursor protein by inducing the metalloprotease gene ADAM17
    Daniel Carnicero-Senabre, José Jiménez-Villegas, Sofía Álvarez-Garrote, Maribel Escoll, Antonio Cuadrado, Ana Isabel Rojo · 2024 · Free Radical Biology and Medicine
  29. Glucose Metabolism, Lactate, Lactylation and Alzheimer’s Disease
    Shuangshuang Hai, Yadan Hou, Meiyan Zhang, Xiaoyan Gao, Tuo Yang, Xiuli Shang, Xiaohong Sun · 2025 · Aging and Disease
  30. Autophagy-Dependent Increased ADAM10 Mature Protein Induced by TFEB Overexpression Is Mediated Through PPARα
    Hongjie Wang, Mohan Kumar Muthu Karuppan, Madhavan Nair, Madepalli Krishnappa Lakshmana · 2021 · Molecular Neurobiology
  31. Dropping the BACE: Beta Secretase (BACE1) as an Alzheimer’s Disease Intervention Target
    Justin L. Read, Cenk Suphioglu · 2013 · InTech eBooks
  32. Human Cord Blood Serum-Derived APP α-Secretase Cleavage Activity is Mediated by C1 Complement
    Ahsan Habib, Darrell R. Sawmiller, Huayan Hou, Manasa Kanithi, Jun Tian, Zeng Jin, Dan Zi, Zhixu He, Paul R. Sanberg, Jun Tan · 2018 · Cell Transplantation
  33. Therapeutic effects of a novel synthetic α-secretase
    Sung Bin Kim, Bo-Ram Mun, Sung Yoon Kim, Muthukumar Elangovan, Euy Jun Park, Won‐Seok Choi, Woo Jin Park · 2024 · Frontiers in Aging Neuroscience
  34. Different Expression Patterns of Amyloid-β Protein Precursor Secretases in Human and Mouse Hippocampal Neurons: A Potential Contribution to Species Differences in Neuronal Susceptibility to Amyloid-β Pathogenesis
    Zhiqiang Xu, Huang Huang, Yali Chen, Yun-Ying Gao, Jun Xu, Charles Marshall, Zhiyou Cai, Ming Xiao · 2016 · Journal of Alzheimer s Disease
  35. The Amyloid Precursor Protein: More than Just Amyloid- Beta
    Stefan D. Jevtic, John Provias · 2019 · Journal of Neurology and Experimental Neuroscience
  36. HIV-Associated Insults Modulate ADAM10 and Its Regulator Sirtuin1 in an NMDA Receptor-Dependent Manner
    Claudia López Lloreda, Sarah Chowdhury, Shivesh Ghura, Elena Alvarez-Periel, Kelly L. Jordan‐Sciutto · 2022 · Cells
  37. Cerebrovascular protective functions of amyloid precursor protein: Progress and therapeutic prospects
    Zvonimir S. Katušić, Livius V. d’Uscio, Tongrong He · 2025 · Pharmacology & Therapeutics
  38. The Effect of TCM-Induced HAMP on Key Enzymes in the Hydrolysis of AD Model Cells
    Xianhui Dong, Dongxue Ma, Tian-Ci Zhang, He Xiao-Ping, Xu Li-Jun, Yalei Liu, Hao Li, Weijuan Gao · 2021 · Neurochemical Research
  39. Aniracetam: An Evidence-Based Model for Preventing the Accumulation of Amyloid-β Plaques in Alzheimer’s Disease
    Robert W.B. Love · 2024 · Journal of Alzheimer s Disease
  40. A Novel scFv Anti-Aβ Antibody Reduces Pathological Impairments in APP/PS1 Transgenic Mice via Modulation of Inflammatory Cytokines and Aβ-related Enzymes
    Meng-Ming Hu, Jun Zhang, Junting Yang, Yue Cao, Jin‐Shun Qi · 2018 · Journal of Molecular Neuroscience
  41. A short peptide from sAPPα binding to BACE1-APP action site rescues Alzheimer-like pathology
    Xia Lai, Jie Hu, He Liu, Ling Lan, Yan Long, Xia Gao, Juan Deng · 2021 · Neuroscience Letters
  42. Blood-based therapies to combat neurodegenerative diseases
    Lee Jy, Mervyn Chen Xi Lim, Rhun Yian Koh, Min Tze Tsen, Soi Moi Chye · 2024 · Metabolic Brain Disease
  43. Tyrosine kinase receptor B isoforms alter APP and BACE1 endogenous levels independently of BDNF
    Sara Ansaloni, Brian Chun Lok Leung, Aditi Dubey, Aleister J. Saunders · 2012 · Advances in Alzheimer s Disease
  44. Stem Cell Approaches for Treatment of Neurodegenerative Diseases
    Saurabh Anand · 2014 · Clinical Pharmacology & Biopharmaceutics
  45. The US9-Derived Protein gPTB9TM Modulates APP Processing Without Targeting Secretase Activities
    Renato Brandimarti, Elena Irollo, Olimpia Meucci · 2022 · Molecular Neurobiology
  46. Novel social stimulation ameliorates memory deficit in Alzheimer's disease model through activating α-secretase
    Qiaoyun Ren, Susu Wang, Junru Li, Kun Cao, Mei Zhuang, Miao Wu, Junhua Geng, Zhengping Jia, Wei Xie, An Liu · 2024 · Journal of Neuroscience
  47. RAGE-Mediated Effects of Formaldehyde in Alzheimer’s Disease
    Ilya G. Mikhailov, Milana S. Mikhailova, Аnton N. Shuvaev, Yana V. Gorina, Оlga S. Belozor · 2025 · Biochemistry (Moscow)
  48. Temporo-spatial cellular atlas of the regenerating alveolar niche in idiopathic pulmonary fibrosis
    Praveen Nilendra Weeratunga, Bethany Hunter, Martin J. Sergeant, Joshua A. Bull, Colin Clelland, Laura Denney, Chaitanya Vuppusetty, Rachel A. Burgoyne, Jeongmin Woo, Tian Hu et al. · 2024 · medRxiv
  49. Fucoxanthin suppresses amyloid-β and pyroglutamate-3-Aβ accumulation by modulating the PI3K/Akt/GSK-3β signaling pathway
    Nayoung Lee, Kumju Youn, Huiyoung Kwon, Jihye Lee, Eunhong Lee, Ji Wook Jung, Minho Moon, Dong‐Seok Lee, Dong Hyun Kim, Chi‐Tang Ho et al. · 2025 · Food & Function
  50. BDNF alters β-cleavage of APP and subcellular distribution of BACE1
    Ryan Douglas Hallam, Gregory Foran, Natasha K. Fletcher, Rebecca E. K. MacPherson, Aleksandar Necakov · 2026 · American Journal of Physiology-Cell Physiology
  51. A lipid-raft theory of Alzheimer's disease
    Ari Rappoport · 2025 · Elsevier eBooks
  52. Structural dynamics and catalytic modulations of Aβ regulating enzymes as future outlook for Alzheimer's
    Sayani Banerjee, Chennu Manisha, Jeyaram Bharathi Jeyabalan, Ashwini Prem Kumar, Antony Justin, Muthiah Ramanathan · 2022 · Biochemical and Biophysical Research Communications
  53. Par-4 in Neuronal Death and Survival in Alzheimer’s Disease and Other Neurogenerative Diseases
    Qing Guo, Jun Xie, Chelsea J. Guo · 2021 · Springer eBooks
  54. Extension domain of amyloid processor protein inhibits amyloidogenic cleavage and balances neural activity in a traumatic brain injury mouse model
    Zhenxing Xie, Tianyu Li, Wei Cheng Su, Yanyun Lou, Yongsheng Zhang, Xiyuan Zhou, Zhanfei Li, Xiangjun Bai, Xinghua Liu · 2023 · CNS Neuroscience & Therapeutics
  55. Neuroplasticity and Alzheimer’s Disease
    Ashkan Asgari Gashtrodkhani, Samaneh Ghorbani Shirkouhi, Seyed Sepehr Khatami, Farzin Kamari, Sarvenaz Ghaedi, Morten Blaabjerg, Sasan Andalib · 2026 · Journal of Integrative Neuroscience
  56. BACE1 Overexpression Reduces SH-SY5Y Cell Viability Through a Mechanism Distinct from Amyloid-β Peptide Accumulation: Beta Prime-Mediated Competitive Depletion of sAβPPα
    Lauren Owens, Joshua Bracewell, Alexandre Benedetto, Neil Dawson, Christopher J. Gaffney, Edward T. Parkin · 2022 · Journal of Alzheimer s Disease
  57. THICAPA modulates amyloid precursor protein processing and alleviates oxidative stress in fibroblasts derived from patients with Familial Alzheimer’s disease
    Danesh Thangeswaran, Shaharum Shamsuddin, Venugopal Balakrishnan · 2025 · Molecular Biology Reports
  58. Mycoplasma hyorhinis markedly degrades β-amyloid peptides in vitro and ex vivo: a novel biological approach for treating Alzheimer's disease?
    Ahsan Habib, Juan Deng, Huayan Hou, Qiang Zou, Brian N. Giunta, Yan‐Jiang Wang, Demian F. Obregon, Darrell R. Sawmiller, Song Li, Takashi Mori et al. · 2013 · Europe PMC (PubMed Central)
  59. Anxiety-like but not despair-like behaviors are further aggravated by chronic mild stress in the early stages of APP swe /PS1dE9 transgenic mice
    Junying Gao, Ying Chen, Dongyuan Su, Charles Marshall, Ming Xiao · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  60. Evaluation of BACE1 silencing as a therapy against Alzheimer disease: implications for lipid metabolism and inflammatory response
    Javier Gustavo Villamil-Ortiz · 2019 · University of Groningen research database (University of Groningen / Centre for Information Technology)
  61. How does neuroprotective sAPPα initiate its signalling cascade
    Joshua R. Prendergast · 2016 · Otago University Research Archive (University of Otago)
  62. The effect of the combination of erythromycin with new beta-lactam antibiotics against gram-negative aerobic respiratory pathogens.
    Masao Nakatomi, Harold C. Neu · 1986 · PubMed
  63. Effects of anle138b treatment on amyloid-β neurotoxicity
    Carolina Thomas · 2020 · eDiss (Georg-August-Universität Göttingen)
  64. TSPO contributes to neuropathology and cognitive deficits in Alzheimer’s disease
    Kelly Ceyzériat, Aurélien M. Badina, Laurene Abjean, Léa Meyer, Farha Bouteldja, Marta Bałkota, Quentin Amossé, Oriane Prudhomme, Ryan J. Middleton, Guo-Jun Liu et al. · 2025 · Research Square
  65. Role of diabetes and altered metabolic homeostasis in age-related dementia
    Tannishtha Biswas, Mehnaz Atiq Ahmed, Sramana Bhowmick, Susmita Mondal · 2025 · Elsevier eBooks
  66. Additional file 5 of Dysregulated expression of miR-140 and miR-122 compromised microglial chemotaxis and led to reduced restriction of AD pathology
    Chao Song, Li, Shufang, Mai, Yingren, Li, Linpeng, Guoku Dai, Zhou, Yuan, Xiaosheng Liang, Olivia Meilan Zou, Wang, Ya, Libing Zhou et al. · 2024 · Figshare
  67. Additional file 3 of Dysregulated expression of miR-140 and miR-122 compromised microglial chemotaxis and led to reduced restriction of AD pathology
    Chao Song, Li, Shufang, Mai, Yingren, Li, Linpeng, Guoku Dai, Zhou, Yuan, Xiaosheng Liang, Olivia Meilan Zou, Wang, Ya, Libing Zhou et al. · 2024 · Figshare
  68. Additional file 1 of Dysregulated expression of miR-140 and miR-122 compromised microglial chemotaxis and led to reduced restriction of AD pathology
    Chao Song, Li, Shufang, Mai, Yingren, Li, Linpeng, Guoku Dai, Zhou, Yuan, Xiaosheng Liang, Olivia Meilan Zou, Wang, Ya, Zhou, Libing et al. · 2024 · Figshare
  69. Additional file 4 of Dysregulated expression of miR-140 and miR-122 compromised microglial chemotaxis and led to reduced restriction of AD pathology
    Chao Song, Li, Shufang, Mai, Yingren, Li, Linpeng, Guoku Dai, Zhou, Yuan, Xiaosheng Liang, Olivia Meilan Zou, Wang, Ya, Libing Zhou et al. · 2024 · Figshare
  70. Additional file 2 of Dysregulated expression of miR-140 and miR-122 compromised microglial chemotaxis and led to reduced restriction of AD pathology
    Chao Song, Li, Shufang, Mai, Yingren, Li, Linpeng, Guoku Dai, Zhou, Yuan, Xiaosheng Liang, Olivia Meilan Zou, Wang, Ya, Zhou, Libing et al. · 2024 · Figshare
  71. Virus-mediated gene transfer of soluble amyloid precursor protein-alpha via systemic injection in a mouse model of Alzheimer’s disease
    Yuanyuan He, Bruce G. Mockett, Lucia Schoderboeck, Kirstin O. McDonald, Barbara J. Logan, Shruthi Sateesh, Owen D. Jones, Stephanie M. Hughes, Wickliffe C. Abraham · 2026 · Gene Therapy
  72. Etude du complexe récepteur 5-HT4/ADAM10/APP et recherche de protéines associées à l’ADAM10 : de nouveaux acteurs favorisant la voie non-amyloïdogénique dans le contexte de la maladie d'Alzheimer
    Romain Donneger · 2014 · theses.fr (ABES)
  73. Implication des métabolites de l'APP dans les troubles mnésiques précoces chez la souris TgCRND8, un modèle de la maladie d'Alzheimer
    Valentine Hamm · 2016 · theses.fr (ABES)
  74. Etude d’une cible thérapeutique pour la maladie d’Alzheimer et mise au point de nouveaux modèles cellulaires de criblage
    Emilie Dorard · 2016 · theses.fr (ABES)
  75. Intérêts des récepteurs 5-HT4 dans la pathologie Alzmeimer : étude préclinique comportementale et électrophysiologie sur tranche d'hippocampe de souris
    Pierre Lecouflet · 2018 · theses.fr (ABES)
  76. Molecular mechanisms of action of MT-MMPs involved in the pathogenesis of Alzheimer’s disease
    Laura García‐González · 2020 · theses.fr (ABES)
  77. Impact des pesticides sur l'agrégation des amyloïdes dans différents modèles de maladies neurodégénératives
    Pierre‐André Lafon · 2019 · theses.fr (ABES)
  78. MT5-MMP promotes neuroinflammation, pathogenic processing of amyloid precursor protein and synaptic dysfunction at early stages in an Alzheimer's disease model
    Dominika Piłat · 2021 · theses.fr (ABES)
  79. Influences biochimiques, anatomiques et cognitives de la troncation exopeptidasique N-terminale du peptide Aβ
    Audrey Valverde · 2020 · theses.fr (ABES)
  80. Unraveling the physiopathological actions of the newly discovered Aη peptides in the brain
    Maria Mensch · 2020 · theses.fr (ABES)
  81. Investigating the physiological function of the amyloid precursor protein in Drosophila melanogaster
    Eirini Kesisoglou · 2020 · theses.fr (ABES)
  82. Early memory deficits and extensive brain network disorganization in the AppNL-F/MAPT double knock-in mouse model of familial Alzheimer's disease
    Christopher Borcuk · 2021 · theses.fr (ABES)
  83. Contribution à l'étude des facteurs de risque pour la maladie d'Alzheimer : analyse de candidats identifiés par étude d'association pangénomique ou GWAS
    Charlotte Bauer · 2023 · theses.fr (ABES)
  84. The light at the end of the tunnel : study of early-stage brain dynamics alterations in Alzheimer’s disease and beneficial effects of light stimulation in the AppNL-F/MAPT mouse model
    Matthieu Aguilera · 2024 · theses.fr (ABES)
  85. A Retrospective CDSS Analysis to Compare Standardized and Non-Standardized Treatment for Central Sensitization Using Systemic Manual Therapy
    Adi Halili, Jessica Mischler · 2026 · Journal of Physical Medicine and Rehabilitation
  86. Second Section: A single domain antibody detects and neutralises toxic Aβ42 oligomers in the Alzheimer’s disease CSF
    Liliana Napolitano · 2026 · Firenze University Press eBooks
  87. References
    Liliana Napolitano · 2026 · Firenze University Press eBooks
  88. Discussion
    Liliana Napolitano · 2026 · Firenze University Press eBooks
  89. Third Section: Design of a dimeric-nanobody specific for Aβ42 oligomers: the Dimeric-DesAb-O
    Liliana Napolitano · 2026 · Firenze University Press eBooks
  90. A multidisciplinary approach for the early diagnosis of Alzheimer’s disease and potential therapeutic applications
    Liliana Napolitano · 2026 · Firenze University Press eBooks
  91. Material and Methods
    Liliana Napolitano · 2026 · Firenze University Press eBooks
  92. First Section: Putative CSF biomarkers of Alzheimer’s disease based on the novel concept of generic protein misfolding and proteotoxicity: the PRAMA cohort
    Liliana Napolitano · 2026 · Firenze University Press eBooks
  93. Introduction
    Liliana Napolitano · 2026 · Firenze University Press eBooks
  94. Conclusion and Future Perspectives
    Liliana Napolitano · 2026 · Firenze University Press eBooks
  95. Ruscus aculeatus Extract Inhibits Amyloid Beta Production and Upregulates the Active form of ADAM10 in Human Neural Progenitor Cells
    Kenta Murata, Yoshiyuki Mizushina, Daisuke Izawa, Yasunori Matsui, Tomoko Wakabayashi, Tadafumi Hashimoto, Takeshi Iwatsubo, Yuji Matsushima · 2026 · Planta Medica